News Filters Display # 5 10 15 20 25 30 50 100 All Filter List of articles in category News Title Source Amicus Therapeutics Presents Scientific Findings and Preclinical Data for Pompe Program Amicus Amicus Therapeutics Announces Positive Preliminary Data from Phase 1/2 Study of Novel Treatment Paradigm for Pompe Disease Amicus 10 Years of Enzyme Replacement Therapy IPA NeoGAA Phase 3 Trial Begins Genzyme BioMarin Update for the Pompe Community Biomarin IPA Statement on Biomarin's June 9th announcement it will seek to out-license BMN-701 Tiffany The Walker Society – a beneficiary research fund in honour of Helen Walker Bruce Walker, brother of Helen Walker Sanofi Genzyme Presents Results from Phase 1/2 Study of Investigational Second-Generation Therapy for Pompe Disease Genzyme BioMarin Announces Interim Analysis of INSPIRE Clinical Trial in Pompe Disease at 34th Annual J.P. Morgan Annual Healthcare Conference Biomarin Amicus Therapeutics Commences Phase 1/2 Study of Novel ERT for Treatment of Pompe Disease Amicus Page 3 of 22 StartPrev12345678910NextEnd
